| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/29/2012 | CN102362974A Traditional Chinese medicine composition for treating urticaria |
| 02/29/2012 | CN102362972A Chinese medicine for treating dermatomyositis |
| 02/29/2012 | CN102362961A Traditional Chinese medicinal formula for treating dermatomyositis |
| 02/29/2012 | CN102362957A Chinese patent medicine for treating deep lupus erythematosus |
| 02/29/2012 | CN102362951A Traditional Chinese medicine for treating psoriasis |
| 02/29/2012 | CN102362950A Traditional Chinese medicine for treating leucoderma |
| 02/29/2012 | CN102362938A Medicine for treating seborrheic alopecia |
| 02/29/2012 | CN102362934A Chinese patent medicine for treating erythema nodosum |
| 02/29/2012 | CN102362930A Chinese medicinal oral liquid for removing chloasma, and preparation process thereof |
| 02/29/2012 | CN102362922A Medicinal liquor for nourishing blood and retaining youthful looks |
| 02/29/2012 | CN102362920A Chinese patent medicament for treating urticaria |
| 02/29/2012 | CN102362919A Traditional Chinese medicine for treating scleroderma |
| 02/29/2012 | CN102362918A Chinese patent medicament for treating scleroderma |
| 02/29/2012 | CN102362897A Use of Hulisan Jiaonang in preparation of medicine for treating scabies |
| 02/29/2012 | CN102362887A Medicinal wine for treating boils |
| 02/29/2012 | CN102362877A Pouzolzia extract, preparation method thereof, and application thereof |
| 02/29/2012 | CN102362873A Use of Xiaomeng oculentum in preparation of medicines for treating alopecia areata |
| 02/29/2012 | CN102362856A Recombinant bovine basic fibroblast grow factor external solution |
| 02/29/2012 | CN102362849A Prickly-heat powder for children |
| 02/29/2012 | CN102362847A Chinese herbal medicine prickly-heat liquid for children |
| 02/29/2012 | CN102362846A Skin radiation-preventing composition |
| 02/29/2012 | CN102362842A Preparation and application of traditional Chinese medicine compound extract with whitening and beverage removing effects |
| 02/29/2012 | CN102106907B Quality control method for rhubarb (traditional Chinese medicine) ethanol-extraction process |
| 02/29/2012 | CN102100749B Chinese medicinal ointment for treating livestock skin pathological changes and preparation method thereof |
| 02/29/2012 | CN102058688B Qingpeng distillate for easing pain and reducing swelling and preparation method thereof |
| 02/29/2012 | CN102038785B Detection method for traditional Chinese medicinal preparation of children eyesight pills |
| 02/29/2012 | CN102018680B Emedastine difumarate sustained release tablets and preparation method thereof |
| 02/29/2012 | CN101991664B Gel agent for treating acnes and preparation method thereof |
| 02/29/2012 | CN101926999B Hemostatic disinfectant and preparation method thereof |
| 02/29/2012 | CN101926973B Chinese medicinal essence capable of penetrating into skin to stop hair loss, remove dandruffs, relieve itching and nourish hair, and preparation method thereof |
| 02/29/2012 | CN101810797B Chinese medicinal preparation for curing psoriasis and preparation method thereof |
| 02/29/2012 | CN101780137B Processing method of honey-fried liquorice |
| 02/29/2012 | CN101618201B Medicine for curing vulvar leukoplakia |
| 02/29/2012 | CN101537002B Diacerein composition with good leaching property, and preparation and use thereof |
| 02/28/2012 | US8124638 Tricyclic compounds useful as angiotensin II agonists |
| 02/28/2012 | US8124590 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/28/2012 | US8124378 Murine zcytor17 ligand polynucleotides |
| 02/28/2012 | US8124356 Methods of purifying zsig33 |
| 02/28/2012 | US8124134 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from Acacia |
| 02/28/2012 | US8124133 Total coumarins include six active compounds, which have been identified as osthal, xanthotoxol xanthotoxin, isopimpinellin, bergapten, imperatorine; little side-effect |
| 02/28/2012 | US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders |
| 02/28/2012 | US8124070 Probiotics for pet food applications |
| 02/23/2012 | WO2012024452A2 Modified relaxin polypeptides and their uses |
| 02/23/2012 | WO2012024223A2 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases |
| 02/23/2012 | WO2012024161A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists |
| 02/23/2012 | WO2012023179A1 Long-acting dermatological antipruritic agent |
| 02/23/2012 | WO2012023146A1 A pharmaceutical composition of reformulated turmeric extract and a method thereof |
| 02/23/2012 | WO2012022795A1 Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor |
| 02/23/2012 | WO2012003554A3 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 02/23/2012 | WO2011134679A3 Selected plant extracts for the treatment of inflammatory diseases |
| 02/23/2012 | US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery |
| 02/23/2012 | US20120046344 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 02/23/2012 | US20120046330 Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof |
| 02/23/2012 | US20120046325 Isoxazoline Compounds Having MIF Antagonist Activity |
| 02/23/2012 | US20120046320 Beta- and gamma-diketones and gamma-hydroxyketones as wnt/beta-catenin signaling pathway activators |
| 02/23/2012 | US20120046318 Methods and compositions for treating internal and external hemorrhoids |
| 02/23/2012 | US20120046317 Novel heterocyclic compounds |
| 02/23/2012 | US20120046311 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2012 | US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors |
| 02/23/2012 | US20120046301 Substituted Cyclic Carboxamide and Urea Derivatives as Ligands of the Vanilloid Receptor |
| 02/23/2012 | US20120046269 Novel Amino Azaheterocyclic Carboxamides |
| 02/23/2012 | US20120046255 Non-steroidal compounds |
| 02/23/2012 | US20120046253 STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY |
| 02/23/2012 | US20120046251 Inhibitors of soluble epoxide hydrolase to inhibit or prevent niacin-induced flushing |
| 02/23/2012 | US20120046243 Aminopyridine- and Aminopyrimidinecarboxamides as CXCR2 Modulators |
| 02/23/2012 | US20120046229 Modified relaxin polypeptides and their uses |
| 02/23/2012 | US20120046217 TNF-alpha Antagonists Containing IGFBP5 |
| 02/23/2012 | US20120045530 Compositions comprising paulownia tomentosa wood extracts and uses thereof |
| 02/23/2012 | US20120045525 Mosquito repellent solution, preparation method and use thereof |
| 02/23/2012 | US20120045503 Compositions And Methods For Wound Healing |
| 02/23/2012 | US20120045500 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 02/23/2012 | US20120045493 Solid Cosmetic Composition with Structurant and Electrolyte Solution |
| 02/23/2012 | US20120045483 Mannitol and/or Proline for Prevention and Treatment of Ageing Related Symptoms |
| 02/23/2012 | US20120045480 composition comprising silver nanoparticles and extracts of polygonum multiflorum thunb and the use thereof |
| 02/23/2012 | US20120045478 Method and compositions |
| 02/23/2012 | US20120045462 Inflammation Inhibiting Compounds |
| 02/23/2012 | US20120045460 Methods and compositions for treatment of graft rejection and promotion of graft survival |
| 02/23/2012 | US20120045458 Use of notch regulators for modulating the immune response by induction/suppression of interleukin-22 |
| 02/23/2012 | US20120045455 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders |
| 02/23/2012 | US20120045454 2,4-pyrimidinediamine compounds and their uses |
| 02/23/2012 | US20120045441 Methods of treating lung disease and other inflammatory diseases |
| 02/23/2012 | US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| 02/23/2012 | US20120045424 Assembly, device kit and method for preparing platelet-rich plasma (prp) |
| 02/23/2012 | US20120045422 Use of lactic acid bacteria to treat or prevent eczema |
| 02/23/2012 | US20120045420 Compositions and improved soft tissue replacement methods |
| 02/23/2012 | US20120045418 Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture |
| 02/23/2012 | US20120045407 Compositions comprising paulownin and/or paulownia extracts and uses thereof |
| 02/23/2012 | US20120045404 Bioactive compositions from theacea plants and processes for their production and use |
| 02/23/2012 | DE102010034699A1 Pyrimidinderivate Pyrimidine derivatives |
| 02/23/2012 | CA2808307A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists |
| 02/22/2012 | EP2420490A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof |
| 02/22/2012 | EP2420240A1 Azithromycin for the treatment of nodular acne |
| 02/22/2012 | EP2420239A2 Antiangiogenic agents |
| 02/22/2012 | EP2420238A2 Anti-angiogenic agents |
| 02/22/2012 | EP2420236A2 Anti-angiogenic agents |
| 02/22/2012 | EP2420230A2 Antiangiogenic agents |
| 02/22/2012 | EP2419439A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate |
| 02/22/2012 | EP2419438A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function |
| 02/22/2012 | EP2419437A1 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions |
| 02/22/2012 | EP2419425A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease |